Skip to main content
ATEX
NASDAQ Technology

Officer Ryan Gerbrandt Files New Intent to Sell $1.06M in Shares, Continuing Recent Sales

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$42.19
Mkt Cap
$790.341M
52W Low
$17.58
52W High
$43.445
Market data snapshot near publication time

Summary

Anterix Inc. officer Ryan L. Gerbrandt has filed a Form 144 indicating intent to sell an additional 25,000 shares worth approximately $1.06 million, following recent sales.


Key Events

  • Proposed Share Sale

    Officer Ryan L. Gerbrandt intends to sell 25,000 common shares of Anterix Inc.

  • Value of Proposed Sale

    The approximate market value of the shares to be sold is $1,064,645.00.

  • Acquisition Method

    The shares intended for sale were acquired through stock option exercises.

  • Recent Selling Pattern

    This filing follows a Form 144 filed yesterday (2026-04-16) by the same officer for 26,889 shares, and previous sales in February and March 2026, indicating a continuous disposition trend.


Analysis

This Form 144 from Officer Ryan L. Gerbrandt signals a continued pattern of share dispositions, coming just one day after a previous Form 144 filing for him. While the proposed sale of $1.06 million represents a relatively small percentage of the company's market capitalization, the repeated intent to sell by a key executive, especially after exercising stock options, could be interpreted as a lack of conviction or a move to diversify holdings. Investors should note the cumulative effect of these sales. This activity occurs while the stock is trading near its 52-week high, potentially indicating the officer is taking advantage of favorable market conditions.

At the time of this filing, ATEX was trading at $42.19 on NASDAQ in the Technology sector, with a market capitalization of approximately $790.3M. The 52-week trading range was $17.58 to $43.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATEX - Latest Insights

ATEX
Jun 10, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $65.00
Real-time Price: $82.81 info
Change: +$17.81 (+27%) info
Market Cap: $1.545B info
ATEX
Jun 10, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.77
Real-time Price: $82.81 info
Change: +$15.04 (+22%) info
Market Cap: $1.545B info
ATEX
May 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $56.80
Real-time Price: $82.81 info
Change: +$26.01 (+46%) info
Market Cap: $1.545B info
ATEX
Apr 21, 2026, 9:16 AM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $42.60
Real-time Price: $82.81 info
Change: +$40.21 (+94%) info
Market Cap: $1.545B info
ATEX
Apr 17, 2026, 4:09 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $42.19
Real-time Price: $82.81 info
Change: +$40.62 (+96%) info
Market Cap: $1.545B info
ATEX
Apr 16, 2026, 4:44 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $40.36
Real-time Price: $82.81 info
Change: +$42.45 (+105%) info
Market Cap: $1.545B info
ATEX
Apr 06, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.86
Real-time Price: $82.81 info
Change: +$43.95 (+113%) info
Market Cap: $1.545B info
ATEX
Apr 01, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.19
Real-time Price: $82.81 info
Change: +$44.62 (+117%) info
Market Cap: $1.545B info
ATEX
Mar 02, 2026, 5:39 PM EST
Filing Type: 144
Importance Score:
8
Price at Filing: $36.03
Real-time Price: $82.81 info
Change: +$46.78 (+130%) info
Market Cap: $1.545B info
ATEX
Feb 11, 2026, 4:46 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $29.70
Real-time Price: $82.81 info
Change: +$53.11 (+179%) info
Market Cap: $1.545B info